How do controlled substance rules affect online ADHD prescriptions?

The rules around controlled substance prescriptions, especially for ADHD medications like stimulants, have been in a state of flux. Here's how they affect online prescriptions:

The Core Issue: The Ryan Haight Act & The Public Health Emergency (PHE)

1. The Ryan Haight Act (2008): This federal law generally requires at least one in-person medical evaluation before a doctor can prescribe a controlled substance. The goal is to prevent illicit online pharmacies and ensure proper medical assessment.
2. The COVID-19 Public Health Emergency (PHE) Waiver: During the pandemic, the Drug Enforcement Administration (DEA) issued a waiver to the Ryan Haight Act. This allowed doctors to prescribe controlled substances, including ADHD stimulants (Schedule II drugs), via telehealth without an initial in-person visit. This is what enabled many online ADHD clinics to boom.
3. PHE Expiration (May 11, 2023) & Transition Periods: The PHE officially ended. This meant the waiver was set to expire. However, due to public outcry and the potential for millions to lose access to care, the DEA has implemented several extensions and proposed new rules:
   • Initial Extension: Patients who established a telehealth relationship for controlled substance prescriptions before November 11, 2023, could continue receiving those prescriptions via telehealth until November 11, 2024.
   • Proposed New Rules: The DEA has proposed two options for future rules, both generally requiring an in-person exam either before or after an initial telehealth prescription for controlled substances. These are still being finalized.
   • Current State: We are in a transition period. While the original waiver is gone, many patients who were already receiving care are still able to do so via telehealth for a limited time. New patients, or those outside the transition period, face stricter rules.

How This Affects Online ADHD Prescriptions

• Stricter Requirements for New Patients: Many online providers are now requiring an initial in-person visit or are only able to prescribe non-stimulant ADHD medications (which are not controlled substances) via telehealth for new patients.
• Focus on Non-Stimulants: Some platforms may prioritize or only offer prescriptions for non-stimulant ADHD medications (e.g., Strattera, Intuniv, Wellbutrin) via telehealth, as these are not subject to the same strict controlled substance regulations.
• Hybrid Models: Some providers are developing hybrid models, partnering with local clinics for initial in-person assessments, or requiring patients to travel for an in-person visit to a limited number of their own physical locations.
• State-Specific Regulations: It's crucial to remember that individual states can have their own telehealth laws that are even stricter than federal guidelines. A provider must comply with both federal and state laws.
• Continuity of Care Concerns: The shifting rules have created uncertainty and anxiety for patients who rely on online prescriptions, potentially leading to interruptions in their treatment.

Specific Brands/Services and How They're Adapting:

It's vital to note that policies can change rapidly. Always check directly with the provider for their most current rules and state availability.

1. Circle Medical:

   • Why: They have generally taken a more cautious and compliant approach from the start. They often utilize an initial in-person visit or partner with local clinics to fulfill the in-person requirement for controlled substances where necessary. They aim for comprehensive care beyond just medication.
   • What to Expect: For stimulant prescriptions, they are likely to require an initial in-person visit (either at one of their physical locations or a partner clinic) or adhere strictly to the evolving federal and state telehealth rules that may allow some initial telehealth prescribing under specific circumstances, followed by in-person.

2. Hims & Hers / Lemonaid Health:

   • Why: These platforms offer a broader range of telehealth services, including mental health. While they do address ADHD, they often start with a comprehensive evaluation and may prioritize non-stimulant options or require an in-person component for controlled substances, depending on state law and current federal guidelines.
   • What to Expect: Likely to be very compliant with current federal and state rules. For stimulants, anticipate a need for an in-person visit or a focus on non-stimulant medications if a full telehealth stimulant prescription isn't permissible in your state or under current DEA guidelines.

3. Done Global / Cerebral:

   • Why: These platforms faced significant scrutiny and legal issues in the past regarding their prescribing practices for controlled substances, particularly during the PHE waiver period. As a result, they have significantly tightened their policies.
   • What to Expect: They are now much stricter. Many have paused accepting new ADHD patients for stimulant prescriptions, or require a mandatory in-person visit for evaluation before prescribing any controlled substances. They may focus more heavily on non-stimulant options if they are prescribing via telehealth. It's crucial to verify their current state-by-state policies directly.

4. Local Telehealth Providers / University Telehealth Programs:

   • Why: Sometimes, a local clinic or a university medical center offers its own telehealth services. These are often integrated with in-person care, making compliance with the Ryan Haight Act easier as they can facilitate an in-person visit when required.
   • What to Expect: This can be a reliable option as they often have a clearer path to fulfilling both telehealth and in-person requirements within the same system.

Key Takeaways for Consumers:

• Verify Your State's Rules: Telehealth regulations vary by state. What's allowed in one state might not be in another.
• Ask Upfront: Before signing up for any service, clearly ask about their current policy for prescribing controlled substances for ADHD, specifically if an in-person visit is required for new patients.
• Beware of "Easy Prescriptions": Be extremely cautious of any online service that promises quick or guaranteed stimulant prescriptions without thorough evaluation or clear explanation of their compliance with federal and state laws.
• Comprehensive Care: Look for providers who offer more than just medication, including therapy, lifestyle recommendations, and robust follow-up care.

The landscape for online ADHD stimulant prescriptions is complex and evolving. It's essential to stay informed and choose a provider that prioritizes patient safety and regulatory compliance.